
A single batch of a common blood pressure pill is being pulled from shelves nationwide because it may contain tiny bits of metal sharp enough to cut a patient’s throat, stomach or intestines.
Quick Take
- Breckenridge Pharmaceutical recalled one lot of Propranolol Hydrochloride Extended-Release Capsules, 60 mg, over possible metal contamination.
- The affected bottles carry NDC 51991-817-01, lot number PK25110035, and an expiration date of May 2029.
- The company says metal could cause cuts in the mouth, throat, stomach, or intestines, though no injuries have been reported.
- The lot shipped nationwide to wholesalers and pharmacies between October 26 and November 4, 2026.
What The Recall Notice Actually Says
Breckenridge Pharmaceutical announced the voluntary, nationwide, consumer-level recall on November 16, 2026. The company pulled one specific lot of its propranolol capsules, a drug widely prescribed to control high blood pressure and heart rhythm problems. The recall notice names the exact product, package size, and identifying numbers so patients can check their own bottles against the warning.
Patients should look for 100-count bottles with NDC 51991-817-01, lot number PK25110035, and an expiration date of May 2029. Breckenridge says that information came directly from the bottle label, making it easy to match at home without needing a pharmacist to decode anything.
How Serious Is The Injury Risk
Breckenridge spelled out the danger in blunt medical language. The company said use of capsules from the affected lot “could potentially cause lacerations of soft tissues in the oral cavity, esophagus, stomach, or intestine.” That means a patient swallowing a contaminated capsule could risk internal cuts in the mouth, throat, or digestive tract.
The company traced the problem to shared manufacturing material. Breckenridge said the recalled lot “shared intermediate material suspected to be the source of metal contamination identified in a separate lot that was not released to market.” In plain terms, a batch of raw material used to make the pills was flagged for metal contamination in an earlier production run, and this recalled lot used material from that same source.
Why The Company Acted Before Confirming Every Capsule
Federal guidelines on pharmaceutical manufacturing direct companies to assess which lots might be affected once foreign material turns up anywhere in a production stream, rather than waiting to prove contamination in every single pill. That standard explains why Breckenridge moved on this lot even though the public notice does not confirm a metal fragment was pulled from a marketed capsule.
Metal and foreign-material recalls are not rare in the drug industry. Federal recall records show past cases involving glass particles, cellulose, polystyrene, and even stainless steel turning up in injectable medicines and other products. Companies in those cases, like Breckenridge now, acted on the side of caution once a contamination risk was identified anywhere in the supply chain.
What Patients And Pharmacies Are Being Told To Do
Breckenridge instructed anyone with the affected lot to stop taking it immediately and call their doctor or pharmacist for a replacement. Patients are told to return unused capsules to their pharmacy rather than throw them away or keep them on hand. Wholesalers and pharmacies nationwide were also told to check their own inventory for the flagged lot number.
That guidance creates a real balancing act for patients on blood pressure medication. Propranolol controls a serious cardiovascular condition, so stopping it abruptly without a doctor’s input carries its own risks. The recall notice tries to address that by pointing patients toward their prescriber rather than simply telling them to quit cold turkey.
No Injuries Reported So Far
As of the announcement, Breckenridge reported no adverse events tied to the recalled lot. That is a meaningful detail. It means the company is acting on a manufacturing-safety finding, not responding to patients who have already been hurt. The precaution is built on preventing a possible harm, not cleaning up after one.
đź’Š BLOOD PRESSURE MEDICATION RECALLED NATIONWIDE OVER POSSIBLE METAL CONTAMINATION
Breckenridge Pharmaceutical Inc. issued a voluntary nationwide recall for one lot of 60 mg propranolol hydrochloride extended-release capsules (lot PK25110035, expiring May 2029) over potential…
— Erik Hoffmann (@TheErikHoffmann) November 17, 2026
The recall covers capsules distributed nationwide over roughly ten days in late October and early November 2026, meaning the affected pills could be sitting in pharmacies or medicine cabinets in nearly any state. Anyone taking propranolol extended-release capsules should check their bottle against the specific lot number before their next dose.
Sources:
washingtontimes.com, prnewswire.com, kmbc.com, wtsp.com, kbtx.com, houstonchronicle.com, fda.gov
© totalconservative.com 2026. All rights reserved.













